Suppr超能文献

惊恐障碍的药物治疗管理。

Pharmacological management of panic disorder.

机构信息

Psychiatric Section, Department of Neuroscience, University of Parma Parma, Italy.

出版信息

Neuropsychiatr Dis Treat. 2008 Feb;4(1):93-106. doi: 10.2147/ndt.s1557.

Abstract

Panic disorder (PD) is a disabling condition which appears in late adolescence or early adulthood and affects more frequently women than men. PD is frequently characterized by recurrences and sometimes by a chronic course and, therefore, most patients require long-term treatments to achieve remission, to prevent relapse and to reduce the risks associated with comorbidity. Pharmacotherapy is one of the most effective treatments of PD. In this paper, the pharmacological management of PD is reviewed. Many questions about this effective treatment need to be answered by the clinician and discussed with the patients to improve her/his collaboration to the treatment plan: which is the drug of choice; when does the drug become active; which is the effective dose; how to manage the side effects; how to manage nonresponse; and how long does the treatment last. Moreover, the clinical use of medication in women during pregnancy and breastfeeding or in children and adolescents was reviewed and its risk-benefit balance discussed.

摘要

惊恐障碍(PD)是一种致残性疾病,多在青少年晚期或成年早期出现,且女性发病率高于男性。PD 常反复发作,有时呈慢性病程,因此大多数患者需要长期治疗以达到缓解,预防复发,并降低共病相关风险。药物治疗是 PD 最有效的治疗方法之一。本文综述了 PD 的药物治疗管理。临床医生需要回答许多关于这种有效治疗的问题,并与患者讨论,以提高患者对治疗计划的配合度:哪种药物是首选;药物何时起效;有效剂量是多少;如何处理副作用;如何处理无应答;治疗持续多长时间。此外,还回顾了药物在妊娠期和哺乳期妇女、儿童和青少年中的临床应用,并讨论了其风险-效益平衡。

相似文献

1
Pharmacological management of panic disorder.
Neuropsychiatr Dis Treat. 2008 Feb;4(1):93-106. doi: 10.2147/ndt.s1557.
2
Panic disorder in children and adolescents.
Yonsei Med J. 2003 Feb;44(1):174-9. doi: 10.3349/ymj.2003.44.1.174.
3
4
[Pharmacotherapy of panic disorder].
Encephale. 1996 Dec;22 Spec No 5:46-53.
6
Diagnosis and management of panic disorder in older patients.
Drugs Aging. 2003;20(12):881-91. doi: 10.2165/00002512-200320120-00002.
7
Panic disorder: efficacy of current treatments.
Psychopharmacol Bull. 1993;29(4):477-86.
8
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
Med J Aust. 2021 Oct 4;215 Suppl 7:S3-S32. doi: 10.5694/mja2.51254.
9
Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient.
Clin Psychopharmacol Neurosci. 2019 May 31;17(2):145-154. doi: 10.9758/cpn.2019.17.2.145.
10
The prediction of nonresponse to pharmacotherapy in panic disorder: a review.
Depress Anxiety. 2001;14(2):112-22. doi: 10.1002/da.1053.

引用本文的文献

1
Pharmacokinetics of intranasal amiloride in healthy volunteers.
Clin Transl Sci. 2023 Jun;16(6):1075-1084. doi: 10.1111/cts.13514. Epub 2023 Mar 27.
2
Real-world outcomes of an innovative digital therapeutic for treatment of panic disorder and PTSD: A 1,500 patient effectiveness study.
Front Digit Health. 2022 Nov 17;4:976001. doi: 10.3389/fdgth.2022.976001. eCollection 2022.
3
Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient.
Clin Psychopharmacol Neurosci. 2019 May 31;17(2):145-154. doi: 10.9758/cpn.2019.17.2.145.

本文引用的文献

1
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27. doi: 10.1002/bdrb.20099.
2
Panic disorder in clinically referred children and adolescents.
Child Psychiatry Hum Dev. 2007 Jun;38(1):57-71. doi: 10.1007/s10578-006-0042-5. Epub 2006 Dec 21.
3
ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.
Obstet Gynecol. 2006 Dec;108(6):1601-3. doi: 10.1097/00006250-200612000-00058.
4
Anxiety disorders during pregnancy and the postpartum period: A systematic review.
J Clin Psychiatry. 2006 Aug;67(8):1285-98. doi: 10.4088/jcp.v67n0818.
5
Clinical practice guidelines. Management of anxiety disorders.
Can J Psychiatry. 2006 Jul;51(8 Suppl 2):9S-91S.
6
Antidepressant discontinuation syndrome.
Am Fam Physician. 2006 Aug 1;74(3):449-56.
7
The effect of temperament and character on response to selective serotonin reuptake inhibitors in panic disorder.
Acta Psychiatr Scand. 2006 Sep;114(3):203-10. doi: 10.1111/j.1600-0447.2006.00772.x.
8
Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1240-5. doi: 10.1016/j.pnpbp.2006.03.010. Epub 2006 May 6.
9
An open-label trial of risperidone augmentation for refractory anxiety disorders.
J Clin Psychiatry. 2006 Mar;67(3):381-5. doi: 10.4088/jcp.v67n0307.
10
Anxiety disorders: noradrenergic neurotransmission.
Handb Exp Pharmacol. 2005(169):205-23. doi: 10.1007/3-540-28082-0_8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验